Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,375 | 56,135 | 76,570 | 27,357 | 17,492 |
| Marketable Securities | 88,089 | 91,513 | 87,919 | 44,146 | 47,819 |
| Receivables | 8,275 | 12,895 | 10,956 | 9,097 | 24,522 |
| Inventories | 6,916 | 7,114 | 6,765 | 6,170 | 3,846 |
| TOTAL | $158,600 | $175,623 | $190,914 | $95,195 | $102,818 |
| Non-Current Assets | |||||
| PPE Net | 3,249 | 3,343 | 3,628 | 3,422 | 4,936 |
| Other Non-Current Assets | 2,777 | 3,086 | 3,145 | 3,176 | 2,391 |
| TOTAL | $6,026 | $6,429 | $6,773 | $6,598 | $7,327 |
| Total Assets | $164,626 | $182,052 | $197,687 | $101,793 | $110,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,075 | 6,203 | 2,404 | N/A | 5,970 |
| Accounts payable and accrued liabilities | 4,342 | 3,910 | 8,658 | 3,135 | 5,592 |
| Accrued Expenses | 15,023 | 16,455 | 12,272 | 14,369 | 20,625 |
| TOTAL | $34,593 | $31,721 | $36,360 | $24,902 | $39,624 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,762 | 43,613 | 47,389 | 49,772 | 23,782 |
| Deferred Revenues | 5,153 | 5,153 | 13,026 | 7,398 | 7,437 |
| Other Non-Current Liabilities | 2,759 | 2,854 | 2,343 | 1,364 | 921 |
| TOTAL | $90,093 | $95,032 | $94,579 | $96,881 | $74,008 |
| Total Liabilities | $124,686 | $126,753 | $130,939 | $121,783 | $113,631 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,387 | 125,306 | 124,509 | 124,004 | 114,029 |
| Common Shares | 125 | 125 | 124 | 115 | 114 |
| Retained earnings | -445,153 | -424,873 | -408,600 | -382,052 | -360,066 |
| Other shareholders' equity | -46 | 3 | -25 | 17 | 16 |
| TOTAL | $39,940 | $55,299 | $66,748 | $-19,990 | $-3,486 |
| Total Liabilities And Equity | $164,626 | $182,052 | $197,687 | $101,793 | $110,145 |